Filters: Author is Fiellin, David A [Clear All Filters]
"Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone." Journal of general internal medicine 25, no. 7 (2010): 670-4. Abstract
"The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality." Journal of addiction medicine 10, no. 6 (2016): 418-428. Abstract
"The effects of federal parity on substance use disorder treatment." The American journal of managed care 20, no. 1 (2014): 76-82. Abstract
"Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review." Archives of internal medicine 167, no. 3 (2007): 221-8. Abstract
"Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial." JAMA 313, no. 16 (2015): 1636-44. Abstract
"The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions (2015). Abstract
"Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men." Journal of general internal medicine 25, no. 2 (2010): 115-21. Abstract
"Estimating demand for primary care-based treatment for substance and alcohol use disorders." Addiction (Abingdon, England) (2016). Abstract
"Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?" Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 5 (2010): 535-42. Abstract
"Evaluation of a combined online and in person training in the use of buprenorphine." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 39-45. Abstract
"An evidence-based guide to writing grant proposals for clinical research." Annals of internal medicine 142, no. 4 (2005): 274-82. Abstract
"Factors affecting willingness to provide buprenorphine treatment." Journal of substance abuse treatment 36, no. 3 (2009): 244-51. Abstract
"Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 25, no. 4 (2004): 35-40. Abstract
"The first three years of buprenorphine in the United States: experience to date and future directions." Journal of addiction medicine 1, no. 2 (2007): 62-7. Abstract
"Food insecurity and health: data from the veterans aging cohort study." Public health reports (Washington, D.C. : 1974) 130, no. 3 (2015): 261-8. Abstract
"Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications." Journal of general internal medicine 26, no. 9 (2011): 1012-8. Abstract
"Gambling: an addictive behavior with health and primary care implications." Journal of general internal medicine 17, no. 9 (2002): 721-32. Abstract
"Gender and non-medical use of prescription opioids: results from a national US survey." Addiction (Abingdon, England) 103, no. 2 (2008): 258-68. Abstract
"Guideline development for office-based pharmacotherapies for opioid dependence." Journal of addictive diseases 22, no. 4 (2003): 109-20. Abstract
"Guideline-Concordant Management of Opioid Therapy among HIV-Infected and Uninfected Veterans." The journal of pain : official journal of the American Pain Society (2014). Abstract
"Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans." The journal of pain : official journal of the American Pain Society 15, no. 11 (2014): 1130-40. Abstract
"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
"Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
"Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection." Journal of substance abuse treatment 68 (2016): 62-7. Abstract
"Hepatitis C and HIV infections: implications for clinical care in injection drug users." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 1 (2004): 1-20. Abstract
"HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment." Journal of addiction medicine 7, no. 6 (2013): 410-6. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians." Journal of addiction medicine 6, no. 2 (2012): 159-65. Abstract
"Human Immunodeficiency Virus-Testing Practices Among Buprenorphine-prescribing Physicians." Journal of addiction medicine (2012). Abstract
"The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients." Drug and alcohol dependence (2014). Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection." Journal of substance abuse treatment (2014). Abstract
"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics." Addiction science & clinical practice 11, no. 1 (2016): 1. Abstract
"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S39-45. Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Increased Hospital and Emergency Department Utilization by Individuals with Recent Criminal Justice Involvement: Results of a National Survey." Journal of general internal medicine (2014). Abstract
"Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy." Journal of rehabilitation research and development 53, no. 1 (2016): 127-36. Abstract
"Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population." The Journal of clinical psychiatry (2014). Abstract
"Initial strategies for integrating buprenorphine into HIV care settings in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S191-6. Abstract
"Integrating buprenorphine treatment into office-based practice: a qualitative study." Journal of general internal medicine 24, no. 2 (2009): 218-25. Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis." AIDS (London, England) (2017). Abstract
"Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients." Journal of acquired immune deficiency syndromes (1999) 69, no. 2 (2015): 223-33. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Measuring Alcohol Consumption Using Timeline Followback in Non-Treatment-Seeking Medical Clinic Patients With and Without HIV Infection: 7-, 14-, or 30-day Recall." Journal of studies on alcohol and drugs 74, no. 3 (2013): 500-504. Abstract
"Mental health after deployment to Iraq or Afghanistan." JAMA : the journal of the American Medical Association 296, no. 5 (2006): 515; author reply 516.
"A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 20, no. 4 (2011): 343-56. Abstract
"Methadone safety: a clinical practice guideline from the american pain society and college on problems of drug dependence, in collaboration with the heart rhythm society." The journal of pain : official journal of the American Pain Society 15, no. 4 (2014): 321-37. Abstract
